Literature DB >> 11328893

HLA-specific alloantibodies and renal graft outcome.

S Sumitran-Holgersson1.   

Abstract

HLA-specific humoral immunity, as a result of recipient allosensitization, induces hyperacute rejection of allogenic kidney grafts. Cross-match tests are performed to avoid this complication. However, current techniques do not allow determination of HLA-specificity of donor-reactive antibodies in the acute cadaver-donor situation. New methods are described and discussed in this report as well as the alloantibody specificities that are of clinical importance. Alloantibodies not only mediate hyperacute rejection but may also participate in the acute rejection of organ grafts. Clinical associations between early immunological complications, such as acute rejection, in heart, liver and kidney allografted patients and pre-transplantation humoral alloimmunity emphasize the need for proper determination of donor-specific humoral immunity prior to transplantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11328893     DOI: 10.1093/ndt/16.5.897

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

Review 1.  Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.

Authors:  Gerald Schlaf; Beatrix Pollok-Kopp; Wolfgang W Altermann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

2.  Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays.

Authors:  Nataša Katalinić; Marina Fućak; Tajana Crnić; Milena Ćurković; Alma Starčević; Sanja Balen
Journal:  Wien Klin Wochenschr       Date:  2016-10-14       Impact factor: 1.704

Review 3.  Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.

Authors:  Andrew L Lobashevsky
Journal:  World J Transplant       Date:  2014-09-24

Review 4.  Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.

Authors:  Chong Jai Kim; Roberto Romero; Piya Chaemsaithong; Jung-Sun Kim
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 5.  Immunosuppressive properties of mesenchymal stem cells.

Authors:  Mohamed Abumaree; Mohammed Al Jumah; Rishika A Pace; Bill Kalionis
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

6.  Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching.

Authors:  Gerald Schlaf; Beatrix Pollok-Kopp; Till Manzke; Oliver Schurat; Wolfgang Altermann
Journal:  NDT Plus       Date:  2010-09-15

Review 7.  The CD8 T-cell response during tolerance induction in liver transplantation.

Authors:  Yik Chun Wong; Geoffrey W McCaughan; David G Bowen; Patrick Bertolino
Journal:  Clin Transl Immunology       Date:  2016-10-14

8.  Artificially Positive Crossmatches Not Leading to the Refusal of Kidney Donations due to the Usage of Adequate Diagnostic Tools.

Authors:  G Schlaf; B Pollok-Kopp; E Schabel; W Altermann
Journal:  Case Rep Transplant       Date:  2013-03-28

9.  ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates.

Authors:  G Schlaf; K Stöhr; A Rothhoff; W Altermann
Journal:  Case Rep Transplant       Date:  2015-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.